Huntington's disease Flashcards

1
Q

What is Huntington’s disease?

A
  • Neurodegenerative
  • Autosomal dominant-complete penetrance
  • Prevalence around 4-10 per 100,000 (might be 2x as common though)
  • Most commonly presents in mid-life
  • Slow progressive over 20-30 years
  • Cognitive, motor and psychiatric symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the cause of Huntingtons disease?

A
  • Huntingtin gene (HTT) is located on short arm chr 4
  • 5’ end-CAG repeat sequence
  • Protein-extended polyhutamine tail
    • Caused by a mutation of a gene called huntingtin – the disease is when you have >40 repeats of CAG (normal people have 17-21)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How to predict and recognise early onset?

A
  • Onset determined by clinical onset of motor symptoms
  • Relationship between CAG repeat length and age of onset
  • Not predictive on individual basis
  • Other genes that modify onset and phenotype
  • 1.Estimated 50% of variability in onset
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Huntingtin?

A
  • HD gene identified in 1993
  • Chromosome 4
  • Codes for huntingtin protein, it is ubiquitously expressed
  • Cytoplasmic
  • Essential for embryonic dev
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is Huntingtin involved in?

A
  • Intracellular transport
  • Intracellular signalling
  • Metabolism
  • Neurogenesis and formation of CNS
  • Synaptic activity
  • Transcription regulation
  • Anti-apoptopic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What happens to mutant Huntingtin?

A
  • Mutant Huntingtin aggregates (clumps together) and some stages of the aggregation are toxic, and some are protective.
  • Issues arise when mutation either gains or loses a function.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain the pathology of Huntingtons Disease.

A
  • 10-20% reduction in brain weight
  • Decreased striatal volume and cell death
  • Decreased cortical volume and cell death
  • Increased ventricle size
  • Proteinous inclusions throughout brain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What does the disease target predominantly?

A
  • Selective loss of GABA cont medium spiny neurons (MSN) in striatum
  • 1st enkephalin cont MSN (indirect pathway)
  • Later stage: Substance P sont (direct pathway)
  • Cholinrgic interneurones of striatum are spared
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Where does the indirect pathway lead?

A
  • Terminals release GABA onto external Globus Pallidus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Where does the direct pathway lead?

A
  • Terminals release GABA onto internal Globus Pallidus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Explain the direct pathway.

A

(dopamine turns on direct)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Explain the indirect pathway.

A

(Dop turns off indirect)
(Losing Dop=No Movt)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Explain the huntington’s pathway.(Diag)

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain Huntington’s Pathway. (Words)

A
  • Thalamus releasing more glutamate causing overactivity in cortex.
  • Inability to stop movts happening due to the loss of a single cell type in circuit casue shit fuck
  • Overactivity in SNc, therfore compunding the effect
  • Direct pathway further stimulated and Indirect lost
    So even more movement experienced
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is the circuitry of 1 motor circuit and what is it responsible for?

A
  • 1 motor supplementary->Putamen->GP/SN->Thalamus
  • Resonsible for motor symptoms
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the circuitry of Dorsolat prefrontal circuit and what is it responsible for?

A
  • Dorsalat prefrontal->Caudate->GP/SN->Thalamus
  • Cognition symptoms
17
Q

What is the circuitry of Lat orbito-frontal circuit and what is it responsible for?

A
  • Lat orbito-frontal->Caudate->GP/SN->Thalamus
  • Cognition symptoms
18
Q

What is the circuitry of Med orbito-frontal circuit and what is it responsible for?

A
  • Med orbito-frontal->Nuc acc->GP/SN->Thalamus
  • Psychiatric symptoms
  • (Nuc acc is v.imp in reward behaviour, so if lost leads to be less inclined to do things as dont get rewards from things you used to.)
19
Q

What are the early motor symptoms?

A
  • Abnormal eye movts
  • Inapp hand and toe movts
  • General restlessness
20
Q

What are the Midcourse motor symptoms?

A
  • Onset of involuntary movts (Chorea)
  • Hypertonic rigidity and dystonia (slow abnormal movts with inc muscle tone)
21
Q

What are the late stage motor symptoms?

A

Impaired voluntary movts:
* Rigidity
* Bradykinesia
* Dystonia
* Convulsions
* Weight loss
* LEADS to death via pneumonia, choking, chronic skin ulcers or nutritional deficits

22
Q

What are the cognitive symptoms?

A

May procede motor onset by a decade or more.
* Dysexecutive syndrome
* Attention deficits, difficulty switching attention from one task to another
* Impaired insight and judgement
* Forgetfulness
* Language deficits

23
Q

What are the psychiatric symptoms?

A
  • Highly variable over time and between patients
  • May precede motor symptoms by a decade or more
  • Core features:
    1. Anxiety
    2. Depression
    3. Obsessive/compulsive
  • Less common:
  • Hallucinations and delusions
24
Q

What are other significant symptoms?

A
  • Weight loss:
    1. Invol movts, loss app and motiv, dysphagia, metabolic dysf
  • Sleep disturbance
    1. Circadian rhythm disturb, depression, loss of routine,’break through’ inv movts, caffeine intake.
  • Muscle weakness
    1. Primary muscle involvement (inc, mitochondrial dysf), disuse atrophy, nutritional deficiencies
25
Q

How to treat Huntington’s?

A
  • Block dopaminergic transmission-dopamine antagonists (tetrabenazine depletes dopamine-antipsychotic medication e.g. olanzapine is a dopamine antagonist)
  • Drugs that enhance GABA-red action of the thalamus (benzodiazepenes)
  • Speech and physiotherapy